Characterization of Stress Degradation Products of Asenapine by LC-MS/MS and Elucidation of their Degradation Pathway

Jump To References Section

Authors

  • Doppala Madhu
     Department of Chemistry, Koneru Lakshmaiah Education Foundation, Vaddeswaram, Guntur - 522302, Andhra Pradesh ,IN
  • Sireesha Koneru
     Department of Mechanical Engineering, Koneru Lakshmaiah Education Foundation, Vaddeswaram, Guntur - 522302, Andhra Pradesh ,IN
  • Bhagya Kumar Tatavarti
     Department of Chemistry, K.B.N. College (Autonomous), Kothapeta, Vijayawada - 520001, Andhra Pradesh ,IN
  • Kandula Rekha
     Department of Biotechnology, Dr.V.S Krishna Government Degree College, Visakhapatnam - 530022, Andhra Pradesh, India ,IN
  • Venkateswara Rao Anna
     Department of Chemistry, Koneru Lakshmaiah Education Foundation, Vaddeswaram, Guntur - 522302, Andhra Pradesh, India ,IN

Keywords:

Asenapine, Antipsychotic Drug, Bipolar Disorder, Degradation Products (DPs)

Abstract

The investigation aimed to integrate Liquid Chromatography (LC) and Liquid Chromatography-Mass Spectrometry (LC–MS) for precise separation, identification, and characterization of asenapine’s Degradation Products (DPs) without isolating them from reaction mixtures. Asenapine underwent scrutiny under various stress conditions (oxidative, hydrolytic, thermal, and photolytic) following ICH Q1A(R2) guidelines. A total of five distinct degradation products emerged from these stress conditions. The separation of all degradation products was executed utilizing a BDS Y Persil C18 column employing with 0.1 % orthophosphoric acid, acetonitrile, and methanol in the ratio of 50:30:20 (v/v) as mobile phase as an isocratic mode with 231 nm. Elucidation of these degradation products was achieved by scrutinizing their fragmentation pattern and the masses discerned through LC–MS/MS and MSn analysis. These previously unidentified degradation products were ascertained to be 11-chloro-3a,12b-dihydro-1H-dibenzo[2,3:6,7] oxepino[4,5-c]pyrrole (DP 1), 3-(3-chloro-6-methylidenecyclohexa-2,4-dien-1-yl)-4-(cyclohexa-1,4-dien-1-yl)-1- methylpyrrolidine (DP-2), 5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrole 2-oxide (DP 3), 2-(1-methyl-4-phenylpyrrolidin-3-yl)cyclohexa-2,5-dien-1-ol (DP-4) and 13-(cyclohexa-1,3-dien-1-yl)-1-methyl- 4-(6-methylidenecyclohexa-1,4-dien-1-yl)pyrrolidine (DP-5). Based in findings, it was confirmed that the method was appropriate for resolution, identification and quantification of impurity 1 and 2 of asenapine along with its DPs.

Downloads

Download data is not yet available.

Downloads

Published

2024-09-13

How to Cite

Madhu, D., Koneru, S., Tatavarti, B. K., Rekha, K., & Anna, V. R. (2024). Characterization of Stress Degradation Products of Asenapine by LC-MS/MS and Elucidation of their Degradation Pathway. Toxicology International. Retrieved from http://mail.informaticsjournals.com/index.php/toxi/article/view/43048

Issue

Online First

Section

Articles

License

Copyright (c) 2024 Doppala Madhu, Sireesha Koneru, Bhagya Kumar Tatavarti, Kandula Rekha, Venkateswara Rao Anna

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Received 2024-03-25
Accepted 2024-08-16
Published 2024-09-13

 

References

Shen WW. A history of antipsychotic drug development. Compr Psychiatry. 1999; 40(6):407-414. https://doi. org/10.1016/s0010-440x(99)90082-2

Aringhieri S, Carli M, Kolachalam S, Verdesca V, Cini E, Rossi M, et al. Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences. Pharmacol Therapeut. 2018; 192:20-41. https://doi. org/10.1016/j.pharmthera.2018.06.012

Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM. Second-generation versus first-generation antipsychotic drugs for schizophrenia: A meta-analysis. Lancet. 2009; 373(9657):31-41. https://doi.org/10.1016/s0140- 6736(08)61764-x

Stacy P, Frantz J, Miller G, et al. A Narrative Review of the Pathophysiology and Treatment of Methamphetamine- Associated Psychosis. Int J Ment Health Addiction. 2024. https://doi.org/10.1007/s11469-024-01323-y

Bhupatiraju RV, Kasimala BB, Nagamalla L, Sayed F. Structural evaluation of degradation products of loteprednol using LC-MS/MS: Development of an HPLC method for analyzing process-related impurities of loteprednol. Anal Sci Technol. 2024; 37 (2): 98-113.

Bhupatiraju RV, Kumar BS, Tangeti VS, Kandula R, Sayed F. LC and LC-MS/MS studies for identification and characterisation of related substances and degradation products of abrocitinib. Toxicol Int. 2024; 31(2): 321-334. https://doi.org/10.18311/ti/2024/v31i2/36370

Auclair J, Rathore AS. Analytical methods to determine the stability of biopharmaceutical products. LCGC N Am. 2023; 41(1):23–27. https://doi.org/10.56530/lcgc.na.qc1477t9

Varma RB, Rao BS. Gas chromatography-head spaceflame ionization sensor based assessment of four residuary solvents in rivaroxaban bulk medication. Res J Pharm Technol. 2022; 15(11):5158-5163. https://doi. org/10.52711/0974-360x.2022.00868

Bhupatiraju RV, Battula SR, Kapavarapu MVNR, Mandapati VR. Assessment of gas chromatography methodology approach for the trace evaluation of carcinogenic impurity. methyl chloride, in trimetazidine dihydrochloride. Ann Pharm Fr. 2023; 81(1):64-73. https://doi.org/10.1016/j. pharma.2022.06.012

Fagiolini A, Forgione RN, Morana B, Maccari M, Goracci A, Bossini L, et al. Asenapine for the treatment of manic and mixed episodes associated with bipolar I disorder: From clinical research to clinical practice. Expert Opin Pharmacother. 2013; 14(4):489-504.11. https://doi.org/10.1 517/14656566.2013.765859

Shahid M, Walker GB, Zorn SH, Wong EH. Asenapine: A novel psychopharmacologic agent with a unique human receptor signature. J Psychopharmacol. 2009; 23(1):65–73. https://doi.org/10.1177/0269881107082944

Meltzer HY, Dritselis A, Yasothan U, Kirkpatrick P. Asenapine. Nat Rev Drug Discov. 2009; 8:843–844. https:// doi.org/10.1038/nrd3027

Govindarajan N, Koulagari S, Methuku A, Podhuturi S, Venkata RB. Method development and validation of RP-HPLC method for determination of new antipsychotic agent asenapine maleate in bulk and in pharmaceutical formulation. Der Pharmacia Lettre. 2012; 4(6):1805-1810.

Chhalotiya UK, Bhatt KK, Shah DA, Patel JR. Stabilityindicating liquid chromatographic method for the quantification of the new antipsychotic agent asenapine in bulk and in pharmaceutical formulation. Sci Pharm. 2012; 80(2):407–417. https://doi.org/10.3797/scipharm.1112-07

Pansuriya K, Shelat P, Patel H. Development and validation of RP-HPLC method for quantitative determination and estimation of asenapine maleate in bulk and buccal (effervescent) dosage form. Int J Pharm Sci Rev Res. 2020; 2317-2323. https://doi.org/10.13040/IJPSR.0975-8232.11(5).2317-23

Patel K, Joshi D, Kumbhani J, Prajapati V. HPLC method development for estimation of dissolution of antipsychotic drug as sublingual film dosage form. Chem Sci Trans. 2018; 7(3):420-423. https://doi.org/10.7598/cst2018.1495

Patel PS, Patel CN, Patel MM. Analytical method development and validation of RP-HPLC for estimation of asenapine maleate in bulk drug and tablet dosage form. Int J Pharm Res. 2016; 5(4):15-19.

Aarelly K, Thimmaraju MK, Nerella R, Allabotharam S. Method development and validation of asenapine in bulk by RP-HPLC method. J Chem Pharm Res. 2012; 45: 2580- 2584.

Kalpana GL, Devalarao G, Raju MB, Praveenkumar T. Validated stability indicating high performance liquid chromatographic method for the quantification of asenapine maleate. Int J Pharm Sci. 2015; 7(11):61-65.

Shyamala, Swarupa A, Anitha P. Validated stabilityindicating RP-HPLC method for determination of asenapine. Indo Am j pharm sci. 2018; 05(05):4107-4113.

Borkar AA, Gaikwad NJ. UV spectrophotometric and RP-HPLC estimation of drug asenapine in tablet dosage form. Int J Pharm Sci Res. 2016; 7(7):3080-3084. https:// doi.org/10.13040/IJPSR.0975-8232.7(7).3080-84

Al-Nimry SS, Khanfar MS. Validation of an RP-HPLC method for the determination of asenapine maleate in dissolution media and application to study in vitro release from co-crystals. Sci Pharm. 2021; 89(1):14. https://doi. org/10.3390/scipharm89010014

Managuli RS, Kumar L, Chonkar AD, Shirodkar RK, Lewis S, Koteshwara KB, et al. Development and validation of a stability-indicating RP-HPLC method by a statistical optimization process for the quantification of asenapine maleate in lipidic nano formulations. J Chromatogr Sci. 2016; 54(8):290-1300. https://doi.org/10.1093/chromsci/bmw062

Kovatsi L, Titopoulou A, Tsakalof A, Samanidou V. HPLC analysis of antipsychotic asenapine in alternative biomatrices: Hair and nail clippings. J Liq Chromatogr Relat Technol. 2015; 38(18):1666-1670. https://doi.org/10.1080/10826076.2015.1089894

Reddy AVB, Venugopal N, Madhavi G. Simultaneous determination of asenapine and valproic acid in human plasma using LC–MS/MS: Application of the method to support pharmacokinetic study. J Pharm Anal. 2013; 3(6):394-401. https://doi.org/10.1016/j.jpha.2013.04.008

Patel NP, Sanyal M, Sharma N, Patel DS, Shrivastav PS, Patel BN. Determination of asenapine in presence of its inactive metabolites in human plasma by LC-MS/MS. J Pharm Anal. 2018; 8(5):341-347. https://doi.org/10.1016/j. jpha.2018.06.002

De Boer T, Meulman E, Meijering H, Wieling J, Dogterom P, Lass H, et al. Quantification of asenapine and three metabolites in human plasma using liquid chromatography– tandem mass spectrometry with automated solid-phase extraction: Application to a phase I clinical trial with asenapine in healthy male subjects. Biomed Chromatogr. 2012; 26(2):156-165. https://doi.org/10.1002/bmc.1640

ICH Q2(R1) Guideline: Validation of analytical procedures: Text and methodology. International Conference on Harmonization (ICH), IFPMA; 2005.

Bhupatiraju RV, Kumar BS, Peddi P, Tangeti VS. An effective HPLC method for evaluation of process related impurities of letermovir and LC-MS/MS characterization of forced degradation compounds. J Chem Metrol. 2023; 17(2):181- 198. https://doi.org/10.25135/jcm.98.2311.2975

Varma BHR, Rao BS. Gas chromatography-head spacemass spectrometry sensor based quality control of dobutamine hydrochloride bulk material for a mutagenic impurity, 2-bromopropane. Res J Chem Environ. 2023; 27(2):54-61. https://doi.org/10.25303/2702rjce054061

Varma RB, Battula SR, Kapavarapu MVNR, Mandapati VR. A novel rivaroxaban degradation impurity detection by RP-HPLC extraction by preparative chromatography, and characterization by LC-MS, NMR and FT-IR: Analysis of novel impurity in batch samples and tablets of rivaroxaban. Rasayan J Chem. 2022; 15(4):2373-2381. https://doi. org/10.31788/rjc.2022.1547008

Raju PMK, Shyamala P, Narayana BV, Dantuluri HSNR, Bhupatiraju RV. A fast, validated UPLC method coupled with PDA-QDa detectors for impurity profiling in betamethasone acetate and betamethasone phosphate injectable suspension and isolation, identification, characterization of two thermal impurities. Ann Pharm Fr. 2022; 80(6):837-852. https://doi. org/10.1016/j.pharma.2022.03.003